Drug Discovery World

AUGUST 22, 2024

Our lead programme is a gene therapy called ER-100 which allows for expression of three transcription factors Oct-4, Sox-2, and Klf-4 (OSK) which is being tested in two optic neuropathies: non-arteritic anterior ischemic optic neuropathy (NAION) and primary open angle glaucoma (POAG).”

Gene Therapy 59

Gene Therapy Gene Gene Editing In-Vivo 59

XTalks

AUGUST 12, 2020

Xtalks spoke to lead author on the study, Mohamed Abdel-Mohsen, PhD, assistant professor, Vaccine & Immunotherapy Center at the Wistar Institute, about the emerging utility of identifying glycomic, or sugar, signatures on the surface of immune cells to help in their identification and potential targeting.

RNA 52

RNA Protein DNA In-Vivo 52

Drug Discovery World

NOVEMBER 15, 2022

If you want to order gene-length sequences, rather than short oligos for PCR, the waiting times are around two or three weeks at least. Anita Ramanathan outlines four synthetic biology approaches that are improving and accelerating drug discovery. . This way, we can separate erroneous sequences from accurate ones.

DNA 98

DNA Drugs Antibody Engineer 98